Role of Leptin and Adiponectin in Endometrial Cancer

Int J Mol Sci. 2022 May 10;23(10):5307. doi: 10.3390/ijms23105307.

Abstract

Endometrial cancer is the most common malignancy of the female genital tract. Obesity is a strong risk factor for endometrial cancer. Adipose tissue is an active endocrine organ that synthesizes biologically active cytokine peptides, called adipokines. Adiponectin and leptin are the main cytokines of adipose tissue, which may influence the development of metabolic diseases and carcinogenesis. In this scenario, we describe the role of leptin and adiponectin in the development of endometrial cancer. A better understanding of the signalling pathway of these cytokines in endometrial cancerogenesis will provide an opportunity for effective target therapy and may be usable in fertility-sparing treatment. In the future, clinical trials focusing on adipokines, molecular biology, and genetics of the tumour will be needed.

Keywords: adiponectin; endometrial cancer; leptin; signalling pathway.

Publication types

  • Review

MeSH terms

  • Adipokines / metabolism
  • Adiponectin / metabolism
  • Cytokines
  • Endometrial Neoplasms* / genetics
  • Female
  • Humans
  • Leptin* / metabolism

Substances

  • Adipokines
  • Adiponectin
  • Cytokines
  • Leptin

Grants and funding

This research received no external funding.